Impact of clinical pharmacist in resolving drug related problem in acute coronary syndrome

The goal of this investigation was to identify drug-related problems (DRPs) and assess the effects of clinical pharmacist interventions in Acute Coronary Syndrome (ACS) patients. Over a six-month period, 104 patients were evaluated, and the “Pharmaceutical Care Network Europe V9.1” framework was used to classify DRPs. Pharmacists focused on optimizing treatment and improving patient education through the use of patient information leaflets. The most frequently observed DRPs were adverse drug reactions (41.86%) and drug interactions (27.90%). A total of 73.2% of DRPs were successfully resolved. Furthermore, quality of life, as measured by the WHOQOL-BREF scale, showed significant improvement (p < 0.005), underlining the critical role of clinical pharmacists in patient care. This study emphasizes the importance of clinical pharmacist interventions in the early detection and resolution of DRPs, which can significantly enhance treatment outcomes and improve the overall quality of life for ACS patients. The findings highlight the essential role that clinical pharmacists play in optimizing medication management and promoting patient well-being.